Evidence map›Paper›PMID 41733345›Full record

ArticleJournal of virology2026

A novel glycoform of the rotavirus outer capsid protein VP7 is secreted from polarized cells and activates innate immune cells.

Ashley Nutsford, The Huong Chau, Carol Wang, Ash Sargent, Camren Cullen, Thomas Reilly, Morten Thaysen-Andersen, Anna E S Brooks, John A Taylor

Abstract read
In one paragraph

Article in Journal of virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ashley NutsfordSchool of Biological Sciences, University of Auckland, Auckland, New Zealand.ORCID 0009-0004-4184-0660
The Huong ChauSchool of Natural Sciences, Macquarie University, North Ryde, Australia.ORCID 0000-0002-0697-7301
Carol WangSchool of Biological Sciences, University of Auckland, Auckland, New Zealand.
Ash SargentSchool of Biological Sciences, University of Auckland, Auckland, New Zealand.
Camren CullenSchool of Biological Sciences, University of Auckland, Auckland, New Zealand.
Thomas ReillySchool of Natural Sciences, Macquarie University, North Ryde, Australia.ORCID 0009-0007-6863-0411
Morten Thaysen-AndersenSchool of Natural Sciences, Macquarie University, North Ryde, Australia.ORCID 0000-0001-8327-6843
Anna E S BrooksSchool of Biological Sciences, University of Auckland, Auckland, New Zealand.ORCID 0000-0003-3551-6982
John A TaylorSchool of Biological Sciences, University of Auckland, Auckland, New Zealand.ORCID 0000-0002-9060-4726

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rotaviruses (RVs) are unique among non-enveloped animal viruses encoding a structural and a nonstructural glycoprotein in their genome. The outer capsid of the virion is formed by 260 trimers of VP7, which is glycosylated at an asparagine residue(s) in the endoplasmic reticulum of infected cells, where it is retained until a late stage of virion morphogenesis. We investigated the fate of VP7 produced during synchronous infection of polarized Caco-2 cells and observed that a previously undetected form with a molecular weight greater than virion-associated VP7 was secreted into the medium. This secreted form of VP7 (sVP7) was not associated with virions and was insensitive to endoglycosidase H treatment consistent with the dominance of complex type N-glycans revealed in structural details using LC-MS/MS. We also detected core 1 and 2-type O-glycans on sVP7 contributing to the higher-than-predicted molecular weight. Purification of sVP7 from the medium of virus-infected cells revealed that it was trimeric and retained conformationally sensitive epitopes recognized by neutralizing monoclonal antibodies. Like the secreted nonstructural protein 4(NSP4), sVP7 exhibited agonism of TLR2 and TLR4 and caused activation of innate immune cells in human blood. Our results identify a novel form of the rotavirus capsid glycoprotein previously undetected and suggest that VP7 may possess extracellular functions beyond its role in the virion as a modulator of innate and adaptive antiviral immunity.IMPORTANCERotavirus (RV) exhibits a mode of assembly unique among non-enveloped animal viruses whereby virion morphogenesis occurs within an endomembrane compartment. The outer shell of rotavirus is assembled within the lumen of the ER where a glycoprotein VP7 is transferred to immature particles that bud from cytoplasmic inclusions. Lytic release of virions from non-polarized cells has obscured the fate of rotavirus glycoproteins from cells with a differentiated phenotype. This study reveals that in polarized cells, a significant proportion of VP7 is secreted, independently of virions, and acquires novel glycan signatures through extensive modification of N- and O-linked glycosylation within the medial Golgi complex. Secreted VP7 exhibited agonism of Toll-like receptors and activated several distinct subsets of innate immune cells while retaining conformationally dependent neutralizing epitopes associated with a trimeric structure indicating a potential role for the secreted capsid glycoprotein in modulating both innate and adaptive immune responses to rotavirus infection.

Indexed as

Antigens, ViralCapsid ProteinsImmunity, InnateRotavirusCaco-2 CellsGlycosylationHumansPolysaccharidesAntigens, ViralCapsid ProteinsPolysaccharidesVP7 protein, RotavirusglycomicsglycoproteinrotavirusVP7

Identifiers

PMID41733345
PMCPMC13011347

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.